Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo

Authors
Publication date
1 January 2004
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      University of Groningen

      redirect
      oaioai:pure.rug.nl:publications/6...
      Last time updated on 29/10/2019

      Dissertations of the University of Groningen

      redirect
      oaioai:pure.rug.nl:openaire_cris_...
      Last time updated on 22/04/2023

      Enlighten: Publications

      redirect
      oaioai:eprints.gla.ac.uk:21529
      Last time updated on 09/04/2020

      Dissertations of the University of Groningen

      redirect
      oaioai:pure.rug.nl:publications/6...
      Last time updated on 02/06/2022

      Proceedings - University of Groningen

      redirect
      oaioai:pure.rug.nl:openaire_cris_...
      Last time updated on 22/04/2023

      Proceedings - University of Groningen

      redirect
      oaioai:pure.rug.nl:publications/6...
      Last time updated on 01/06/2022

      ARTS repository - University of Groningen

      redirect
      oaioai:pure.rug.nl:publications/6...
      Last time updated on 03/06/2022

      ARTS repository - University of Groningen

      redirect
      oaioai:pure.rug.nl:openaire_cris_...
      Last time updated on 22/04/2023

      Enlighten

      redirect
      oaioai:eprints.gla.ac.uk:21529
      Last time updated on 08/10/2012

      NARCIS

      redirect
      Last time updated on 15/10/2017